Hi Upxdn ... up until quite recent (late last year), PYC was a cancer company testing, trialling and developing iMYC and omoMYC. OmoMYC is the Laura Soucek solution but wouldn’t work in people. Enter PYC who worked with the Soucek solution and own in-house solution to demonstrate in-Vito/vitro that MYC had potential in conjunction with peptides. Soucek and PYC had been in discussions for some time. However, late last year PYC shifted strategy and sidelined the iMYC/omoMYC work (albeit there is a research grant ticking along) due to the long lead time to develop. Several on this forum have been calling for a PYC/Soucek collaboration. Sidelining the MYC work co-incided with a big drop in the share price at the time. Just saying.
So, i’m Hopeful that a collaboration deal is being worked on with Soucek.
PYC Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)